Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Other material
confidence 65%
filed 2026-05-21
Item 8.01
Apyx Medical announced publication of clinical data in a peer-reviewed journal (Aesthetic Surgery Journal Open Forum) demonstrating efficacy for cellulite and skin laxity treatment. While this is a positive clinical validation event relevant to the company's product portfolio and market positioning, it does not fit neatly into the more specific event categories (not earnings, M&A, litigation, impairment, etc.). The disclosure is material to investors assessing the company's clinical evidence base and competitive standing in aesthetic medicine, but the ambiguity about whether this constitutes a "material" event versus routine clinical publication reporting warrants moderate confidence.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
Item 7.01
The company reaffirmed FY2026 guidance while disclosing an ongoing CEO and CFO search process and highlighting material risks of executive attrition and Board transition. The forward-looking statements emphasize management continuity challenges tied to ongoing executive leadership transitions.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
The filing discloses announcement of tokenized equity listing on xStocks via press release (Exhibit 99.1), filed under Item 7.01 (Regulation FD Disclosure). This represents a material corporate development—the introduction of a blockchain-based equity instrument—that does not fit cleanly into standard 8-K categories (not M&A, not earnings, not an executive change). The tokenization of equity is a novel capital structure event that would affect investor assessment of the company's business model and equity structure.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
The filing discloses interim clinical trial results from the Phase 2 NEXICART-2 trial showing that all four MRD-negative relapsed/refractory AL Amyloidosis patients have converted to complete response (CR), with a 95% CR rate (19/20) across the first 20 patients and no relapses observed. While this is positive clinical progress for a biopharmaceutical company's lead candidate, it does not fit neatly into the standard event taxonomy—it is neither an earnings release (no financial results), nor a material impairment, litigation, M&A activity, or executive change. The disclosure is material to investors assessing the company's pipeline and regulatory prospects, but the event is best classified as other_material given the clinical-trial-update nature of the announcement.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
The filing discloses under Item 8.01 (Other Events) that Ocean Power Technologies announced an expansion in its global deployment footprint across U.S. government, international, and research customers via press release. While the specific details of the expansion are not provided in the 8-K body itself, the announcement of expanded deployment across government and international customers could be material to investors assessing the company's growth trajectory and market reach. However, without the full press release text, the precise materiality and nature of the event cannot be definitively categorized into a more specific event type, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
The filing discloses a shareholder letter regarding "strategy overview and business update" under Item 8.01 (Other Events). Without access to the actual letter content (Exhibit 99.1), the materiality and specific nature of the update cannot be determined with certainty. However, a formal shareholder letter on strategy and business update filed via 8-K suggests material developments that would affect investor assessment, warranting classification as other_material rather than a more specific event type.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
The filing discloses that ARC Group Acquisition I Corp announced the commencement of separate trading of its unit components (Class A ordinary shares, warrants, and rights) on NASDAQ effective May 28, 2026. This is a structural capital markets event following the company's recent IPO completion (May 5-7, 2026), but does not fit neatly into the standard taxonomy categories. While material to investors as it affects trading mechanics and liquidity of the company's securities, it is neither an earnings release, executive change, M&A activity, nor a financial restatement or impairment.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
This Item 8.01 discloses the issuance and sale of approximately $472.9 million in commercial mortgage pass-through certificates by BBCMS Mortgage Trust 2026-5C41, a securitization vehicle. While the filing describes the transaction structure, underwriters, and credit risk retention compliance under Regulation RR, it does not fit neatly into the standard 8-K event taxonomy (e.g., not an earnings release, M&A activity, restatement, or going-concern disclosure). The transaction is material to investors in the certificates and the registrant's stakeholders, but the disclosure is primarily informational about a completed securitization closing rather than a discrete corporate event triggering a specific Item category.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
Item 8.01
The Board of Directors approved a cash dividend of $0.20 per share payable on June 15, 2026.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
Item 7.01
The disclosure describes a "Segment Realignment" following the NDS acquisition, where ADS consolidated reportable segments from "Infiltrator" into "Stormwater and Wastewater" and changed the profitability metric from adjusted gross profit to Adjusted EBITDA. While segment restatements and metric changes are material to investors assessing operational performance, this does not fit the specific restatement category (Item 4.02 language is absent—the company explicitly states it "does not amend or restate any of the Company's previously issued financial statements"). The realignment is disclosed under Item 7.01 (Regulation FD Disclosure) as supplemental information, making it a material disclosure that falls outside the more specific event categories.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
Item 1.01
Talen Energy amended its credit agreement on May 20, 2026, repricing three facilities totaling approximately $2.585 billion (Initial Term B: $846M, 2024-1 Incremental Term B: $839M, Revolving: $900M) and extending the maturity of the Initial Term B Facility from May 2030 to November 2032. While this is a material definitive agreement under Item 1.01, it does not fit cleanly into the M&A activity category—it is a refinancing/repricing of existing debt rather than an acquisition, disposition, merger, or change of control. The amendment reduces interest margins (ABR margin from unspecified to 0.75%/0.50%, Term SOFR margin to 1.75%/1.50%) and extends maturity, which is material to investors assessing the company's capital structure and debt obligations, but the event is primarily a debt restructuring rather than a discrete M&A transaction.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
Item 1.02
HawkEye 360 terminated two material loan agreements (Senior Term Loan with Silicon Valley Bank and Mezzanine Loan with First-Citizens Bank) following full repayment on May 18, 2026, with release of all security interests, representing a significant deleveraging event.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
The company disclosed a material change in reportable segments from two segments (buy-side and sell-side) to one consolidated digital marketing segment, and implemented a 4-to-1 reverse stock split effective April 27, 2026. The segment restructuring and recast financial statements materially affect investors' understanding of the company's operational structure and historical financial performance.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
Item 7.01
This Item 7.01 disclosure presents portfolio commentary and performance metrics for TCAP as of March 31, 2026, including year-to-date and trailing twelve-month returns (2.5% and 10.3% respectively), portfolio composition statistics, and market analysis. While the disclosure contains material performance information relevant to investors in the fund, it does not fit neatly into the specific event categories (e.g., it is not an earnings release with formal financial statements, nor does it announce a specific corporate action like M&A, executive changes, or covenant breaches). The commentary is primarily informational and forward-looking rather than announcing a discrete material event, making "other_material" the most appropriate classification for this portfolio update disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
Item 2.03
This Item 2.03 disclosure describes the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of New York. While the filing explicitly states "consolidated obligations issuance is material to the Bank," the disclosure is primarily informational and regulatory in nature—explaining the structure, joint-and-several liability framework, and reporting methodology for consolidated obligations rather than announcing a specific new debt issuance event. The absence of a Schedule A with specific issuance details in the provided text, combined with the general explanatory tone, suggests this may be a routine periodic disclosure rather than a discrete material event triggering Item 2.03. Classified as other_material because the disclosure addresses material financial obligations but does not fit cleanly into covenant_breach or other specific event categories.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
Item 8.01
The filing discloses a dividend declaration by the FHLBNY Board of Directors for Q1 2026, announced via a President's Report to members. While dividend declarations are material to shareholders/members, this does not fit the earnings_release category (which typically involves comprehensive financial results) nor any other specific event type. The disclosure is material to members' assessment of the institution's capital distribution policy and financial health, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 7.01
The FDA reclassified Bioventus's Exogen bone growth stimulator from Class III to Class II, triggering CMS updates to Medicare reimbursement rates effective May 18, 2026. While the company states it does not presently expect a material impact on 2026 results and is reiterating guidance, the disclosure acknowledges potential long-term impacts and notes that "further changes by CMS...could require the Company to revise its financial outlook." This regulatory change affecting a core product's reimbursement is material to investors, though it does not fit neatly into the more specific event categories (not a restatement, impairment, or covenant breach, but a significant regulatory development with acknowledged future financial uncertainty).
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
Item 8.01
The disclosure announces release of interim Phase 2 clinical trial data for FID-007 in combination with cetuximab for head and neck squamous cell carcinoma. While clinical trial results can be material to biotech/pharma investors, this filing lacks specificity about the trial outcomes, efficacy metrics, or clinical significance—it merely announces that an abstract was "released" without disclosing the actual results. This appears to be a clinical milestone announcement rather than a traditional earnings release or material event with clear financial/operational impact, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
Item 7.01
Z Squared Inc. announced a Phase 1 plan to reach 100 MW of AI-ready infrastructure capacity for inference workloads via press release on May 19, 2026. This disclosure under Item 7.01 (Regulation FD Disclosure) represents a material business development or strategic initiative that would affect a reasonable investor's assessment of the company's growth trajectory and capital deployment plans, but does not fit neatly into the more specific event categories (not an earnings release, M&A activity, executive change, or financial restatement). The announcement of significant infrastructure expansion capacity is material to investors evaluating the company's operational strategy and competitive positioning.
View raw filing on EDGAR →
8-K
Other material
confidence 35%
filed 2026-05-21
Item 1.01
Chilean Cobalt Corp. entered into a material definitive agreement disclosed under Item 1.01, but the filing text is incomplete and cuts off mid-sentence, making it impossible to determine the specific nature of the agreement or whether it constitutes an acquisition, disposition, merger, or other material transaction.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
The Company disclosed via press release that it failed to file its Form 10-Q for Q1 2026 by the extended deadline of May 20, 2026. This is a material disclosure of non-compliance with SEC filing requirements that would affect investor assessment of the registrant's operational and regulatory standing. While this could signal delisting risk or other underlying issues, the disclosure itself centers on the filing delinquency rather than a specific delisting notice or going-concern statement.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
Liberty Latin America announced and issued Series A Preference Shares (9.0% Fixed Rate Cumulative Perpetual Redeemable) distributed as a special dividend at a 1-for-10 ratio to common shareholders. The new preferred shares carry material economic terms including fixed dividend accrual, liquidation preferences, optional redemption rights, and conditional director election rights triggered by dividend non-payment, materially affecting the company's capital structure and future cash obligations.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
Zentalis announced Phase 1b clinical trial data for azenosertib in combination with paclitaxel in platinum-resistant ovarian cancer patients, demonstrating an ORR of 39.1% and median PFS of 7.3 months with a manageable safety profile. This represents a significant clinical milestone for the company's lead drug candidate.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
Item 8.01
The board declared a dividend distribution of $0.071 per share, with the net asset value per share as of April 30, 2026 reported at $9.77.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
This filing discloses the public issuance of multiple classes of Asset Backed Notes (Class A-1 through Class D) by Carvana Auto Receivables Trust 2026-P2, with the Registrant filing to satisfy an undertaking to provide legality and tax opinions. While the issuance itself is a material financing event, it does not fit neatly into the more specific categories (not a traditional M&A activity, not a dilutive equity issuance, not a restatement or going-concern disclosure). The materiality stems from the significant debt issuance and the formal legal opinions required to support it.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
The Fund disclosed its NAV per share of $24.06 as of April 30, 2026, aggregate NAV of $45.2 billion, portfolio fair value of $79.0 billion, debt outstanding of $37.1 billion, and ongoing public and private offerings totaling $56.8 billion in consideration, reflecting the Fund's substantial size and leverage metrics.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
Item 7.01
FinWise Bancorp announced approval of a share repurchase program via press release on May 21, 2026. While share repurchases are material to investors as they signal capital allocation, confidence in confidence, and management's view of valuation, this disclosure does not fit neatly into the specific taxonomy categories (it is not a dilutive issuance, exec compensation, or earnings release). The event is material but best classified as other_material given the absence of a dedicated repurchase program category.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
Victoria's Secret announced a ticker symbol change from an unspecified prior symbol to VSXY, effective June 2, 2026. While ticker changes are administrative in nature, this disclosure is material to investors as it affects how the security is identified and traded on the NYSE. The event does not fit the delisting_risk category (which concerns failure to maintain listing standards) but represents a significant corporate action that would affect investor ability to trade and track the stock.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
Item 8.01
The company disclosed its net asset value per share of $20.06 as of April 30, 2026, and provided a material update on the status of an ongoing private offering of up to $4.5 billion in Common Stock, noting that 145.2 million shares have been issued for $2.99 billion to date with continued monthly sales planned.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
The Fund disclosed its Transactional NAV calculation and per-unit NAV breakdown as of April 30, 2026, including valuation methodology and component breakdown across multiple share classes. This disclosure is material to investors in determining the pricing and valuation of their units.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 8.01
Lee Enterprises entered into a five-year management agreement with Hoffmann Media Group (owned by the Company's majority shareholder and Chairman David Hoffmann) to manage and operate newspaper publications across multiple states for a fixed quarterly fee of $135,000 plus variable compensation tied to EBITDA. This related-party transaction materially expands Lee's service business model and revenue streams, but does not constitute a traditional M&A activity, executive change, or other more specific event type. The Board approved the arrangement with Mr. Hoffmann recused, indicating governance awareness of the related-party nature.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-20
Item 8.01
The Board approved a $10.00 per share cash dividend payable to common stockholders, representing a material capital allocation decision.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-20
Item 8.01
United Fire Group announced a quarterly cash dividend of $0.20 per share and extended its Share Repurchase Program to August 31, 2028, with authorization increased to 2 million shares. These capital allocation decisions reflect the company's shareholder return strategy and capital deployment priorities.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 5.03
The disclosure describes a two-for-one stock split effected through an amendment to the Articles of Incorporation increasing authorized shares from 20 million to 40 million. While stock splits are routine capital structure adjustments, this one is material to investors as it affects share count, ownership percentages, and per-share metrics. The event does not fit neatly into the specific taxonomy categories (it is neither a dilutive issuance of new equity for capital-raising purposes, nor a traditional M&A or governance event), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 8.01
Starbucks completed a material cash tender offer to repurchase approximately $1.3 billion in aggregate principal amount of senior notes across multiple series, reducing outstanding debt and affecting the company's capital structure and financial position. While this is a debt management activity, it does not fit cleanly into the standard M&A or covenant-breach categories—it is a voluntary debt reduction/refinancing event that would materially affect investor assessment of leverage and liquidity.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 2.05
The company announced a material restructuring plan involving a 17% workforce reduction and site closures, with estimated charges of $300–$340 million primarily for severance and employee benefits.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-20
Item 8.01
The Board approved a $1.20 per share cash dividend with a July 17, 2026 payment date.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-20
Item 7.01
The disclosure announces a board declaration of a cash dividend payable July 1, 2026, filed under Item 7.01 (Regulation FD Disclosure). While dividend declarations are routine corporate actions and material to shareholders, they do not fit cleanly into the specific event taxonomy provided (not earnings, executive changes, M&A, impairment, litigation, etc.). This is classified as other_material because it is a material disclosure affecting investor assessment of capital allocation and shareholder returns, but lacks a dedicated category in the taxonomy.
View raw filing on EDGAR →
8-K
Other material
confidence 55%
filed 2026-05-20
Item 1.01
Amendment No. 2 to the Company's Credit Agreement reduces the Applicable Rate on the U.S. Dollar term loan facility and resets soft call protection, representing a material refinancing or repricing of existing debt that affects the Company's cost of capital and debt structure.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 7.01
The disclosure announces a Board-authorized share repurchase program for up to 1,000,000 shares over two years. While share buybacks are capital allocation decisions that can be material to investors' assessment of the company's financial strategy and use of cash, this event does not fit cleanly into the more specific taxonomy categories (it is not an earnings release, executive change, M&A activity, impairment, or other defined event type). The Item 7.01 Regulation FD Disclosure framework and the company's own cautionary language about materiality create some ambiguity, but the authorization of a material repurchase program would typically affect a reasonable investor's view of capital allocation and shareholder returns.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-20
Item 7.01
The disclosure announces a quarterly dividend declaration of $1.0625 per share, which is material to investors as it affects shareholder returns and reflects the company's capital allocation policy. While dividend announcements are routine for mature companies like Crown Castle, they are typically material to equity investors and warrant disclosure. This does not fit neatly into the provided taxonomy categories, making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-20
Item 8.01
The filing discloses a press release announcing that "AITX's RAD Signs Agreement with Global Healthcare Organization." This appears to be a material business development or contract award with a healthcare organization, but the Item 8.01 disclosure and the cautionary language ("shall not be deemed to be an admission as to the materiality") provide limited detail. Without access to the full press release (Exhibit 99.1), the specific nature of the agreement cannot be definitively classified as M&A activity, a material contract, or another discrete event type, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 55%
filed 2026-05-20
Item 2.03
Innovative Industrial Properties Inc. entered into secured term loan agreements totaling $21.96 million to subsidiaries, with the parent company providing unsecured guaranties. The financing arrangement was disclosed via press release and represents a material financing event affecting the company's capital structure and liquidity.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 8.01
Chubb agreed to sell $1 billion of Senior Notes due 2036 in a public offering, guaranteed by Chubb Limited. While this is a material debt issuance affecting the registrant's capital structure and financial position, it does not fit cleanly into the more specific event categories (e.g., it is not M&A activity, a covenant breach, or a dilutive equity issuance). The disclosure is material to investors as it represents a significant financing event, but the taxonomy lacks a dedicated debt issuance category, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 7.01
Royal Caribbean discloses that SEMARNAT (Mexican environmental authority) will deny approval of environmental permits for the "Perfect Day Mexico" project, a significant capital investment. While this is a regulatory setback rather than a traditional M&A termination, the denial of environmental permits for a major development project materially affects the company's growth strategy and capital allocation plans. The company's commitment to "re-engage stakeholders" suggests the project remains in flux, making this a material event that would affect investor assessment of the company's Mexico expansion prospects.
View raw filing on EDGAR →
8-K
Other material
confidence 55%
filed 2026-05-20
Item 1.01
Hudson Technologies entered into a material definitive agreement, specifically a Fifth Amendment to its revolving credit facility that increases the letter of credit sublimit from $1.5 million to $2.5 million. The amendment represents a routine modification to the company's existing credit arrangements.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 1.01
The filing discloses entry into a Second Amendment to a Revolving Credit and Security Agreement that increases the maximum facility amount from $400 million to $600 million. While this is a material definitive agreement under Item 1.01, it does not constitute a traditional M&A activity (acquisition, disposition, merger, or change of control), nor does it fit the other specific event categories. The amendment represents a material financing arrangement modification that would affect investor assessment of the company's liquidity and capital structure.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 1.01
Gilead entered into an Eleventh Supplemental Indenture on May 20, 2026, governing the issuance of $3 billion in aggregate principal amount of senior notes across four series (2028, 2029, 2031, and 2034 notes) with interest rates ranging from 4.250% to 4.900%. The company intends to use net proceeds for general corporate purposes including potential acquisitions and strategic transactions.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 8.01
Redwood Trust entered into an underwriting agreement on May 19, 2026 to sell $125 million in 9.75% senior notes due 2031, with a 30-day over-allotment option for an additional $18.75 million. This is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, but it does not fit neatly into the more specific event categories (it is not M&A, not a dilutive equity issuance, and not a covenant breach or going-concern disclosure). The disclosure is material as it represents a significant financing event.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-20
Item 8.01
The filing discloses issuance of $997.87 million in Asset Backed Notes on May 20, 2026, with supporting legal opinions from Sidley Austin LLP. While this represents a material financing event for the trust, it does not fit cleanly into the standard M&A or dilutive issuance categories—it is a securitization/ABS issuance by a special-purpose trust vehicle. The disclosure is routine for ABS trusts but material to investors in the notes themselves.
View raw filing on EDGAR →